255 MNOK to biomedical research

The Norwegian Research Council recently announced four large investments in biomedical research on a total of 255 MNOK.

Of these investments, 60 MNOK will go to to sequencing and precision medicine, 80 MNOK to national biobanks, 65 MNOK to brain research and 50 MNOK to Norwegian Clinical Research Infrastructure Network.

– This is great news. Biomedical research affects not only a nation’s health, but international competitiveness too, says Ketil F. Widerberg, General Manager in Oslo Cancer Cluster in a comment.

For more information: http://www.forskningsradet.no/no/Nyheter/13_milliarder_til_forskningsutstyr/1254010677263/p1174467583739